Attendee search 

George Health Enterprises is the commercial arm of The George Institute for Global Health. George Health Medicines (a wholly owned subsidiary of GHE)  is focussed on the late stage development and key territory registration of pharmaceutical products which have resulted from The George Institute's ground-breaking research into the treatment of non-communicable diseases. George Health Medicines is seeking appropriate commercial partners globally for the medicines which it developes. The short term pipeline includes innovative medicines for the prophylaxis of cardiovascular disease and for the primary treatment of hypertension and Type II diabetes.

Exeltis is actively searching for in-licensing products in the areas of Gynecology, Urology and CNS.

As an R&D company, we are searching licensees for some specific territories in the area of gynecology.

A Pan-European Specialty Care Provider located in the hart of Europe aiming at satisfying patients, payers, divesting pharma and investors' needs alike  

Silence Therapeutics is a leading RNAi company, developing highly innovative medicines with life-saving potential for patients with serious and rare diseases, based upon its proprietary technology platform in GalNAc conjugated siRNA.

The Company is in a strong position to maximise the potential of its IP and technology through collaborations and the advancement of internal programmes toward the clinic. Silence’s lead candidate SLN124 will move into clinical development in the coming year.